Advertisement

Ads Placeholder
Loading...

Meilleure Health International Industry Group Limited

2327.HKHKSE
Industrials
Conglomerates
HK$0.26
HK$-0.01(-3.77%)
Hong Kong Market opens in NaNh NaNm

Meilleure Health International Industry Group Limited Fundamental Analysis

Meilleure Health International Industry Group Limited (2327.HK) shows weak financial fundamentals with a PE ratio of 27.36, profit margin of 1.04%, and ROE of 3.08%. The company generates $0.0B in annual revenue with weak year-over-year growth of -60.81%.

Key Strengths

PEG Ratio-8.76
Current Ratio2.81

Areas of Concern

ROE3.08%
Operating Margin-26.67%
Cash Position1.94%
We analyze 2327.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -15.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-15.8/100

We analyze 2327.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

2327.HK struggles to generate sufficient returns from assets.

ROA > 10%
2.09%

Valuation Score

Moderate

2327.HK shows balanced valuation metrics.

PE < 25
27.36
PEG Ratio < 2
-8.76

Growth Score

Weak

2327.HK faces weak or negative growth trends.

Revenue Growth > 5%
-60.81%
EPS Growth > 10%
-21.00%

Financial Health Score

Excellent

2327.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.31
Current Ratio > 1
2.81

Profitability Score

Weak

2327.HK struggles to sustain strong margins.

ROE > 15%
3.08%
Net Margin ≥ 15%
1.04%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 2327.HK Expensive or Cheap?

P/E Ratio

2327.HK trades at 27.36 times earnings. This indicates a fair valuation.

27.36

PEG Ratio

When adjusting for growth, 2327.HK's PEG of -8.76 indicates potential undervaluation.

-8.76

Price to Book

The market values Meilleure Health International Industry Group Limited at 0.83 times its book value. This may indicate undervaluation.

0.83

EV/EBITDA

Enterprise value stands at -73.83 times EBITDA. This is generally considered low.

-73.83

How Well Does 2327.HK Make Money?

Net Profit Margin

For every $100 in sales, Meilleure Health International Industry Group Limited keeps $1.04 as profit after all expenses.

1.04%

Operating Margin

Core operations generate -26.67 in profit for every $100 in revenue, before interest and taxes.

-26.67%

ROE

Management delivers $3.08 in profit for every $100 of shareholder equity.

3.08%

ROA

Meilleure Health International Industry Group Limited generates $2.09 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.09%

Following the Money - Real Cash Generation

Operating Cash Flow

Meilleure Health International Industry Group Limited generates strong operating cash flow of $61.44M, reflecting robust business health.

$61.44M

Free Cash Flow

Meilleure Health International Industry Group Limited generates strong free cash flow of $60.77M, providing ample flexibility for dividends, buybacks, or growth.

$60.77M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

2327.HK converts 5.88% of its market value into free cash.

5.88%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

27.36

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-8.76

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.83

vs 25 benchmark

P/S Ratio

Price to sales ratio

28.37

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.31

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.02

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How 2327.HK Stacks Against Its Sector Peers

Metric2327.HK ValueSector AveragePerformance
P/E Ratio27.3625.96 Neutral
ROE3.08%1263.00% Weak
Net Margin104.01%-41827.00% (disorted) Strong
Debt/Equity0.310.79 Strong (Low Leverage)
Current Ratio2.8110.05 Strong Liquidity
ROA2.09%-1497918.00% (disorted) Weak

2327.HK outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Meilleure Health International Industry Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-77.99%

Industry Style: Cyclical, Value, Infrastructure

Declining

EPS CAGR

243.93%

Industry Style: Cyclical, Value, Infrastructure

High Growth

FCF CAGR

657.46%

Industry Style: Cyclical, Value, Infrastructure

High Growth

Fundamental Analysis FAQ